These results suggested an adverse prognosticator of GCNT2 in AML, and the high frequency of over-expressed GCNT2 in FAB-M4-5 was coincident with the result demonstrated above that monocyte had the unique expression profile of GCNT2. This evidence concerns the gene GCNT2 and acute myeloid leukemia.